
A “smart” approach to monitoring drug levels in real-time
Throughout the COVID-19 pandemic, many physicians having been looking to leverage smart technology to help monitor and track the health...

Snapshot of Select Canadian COVID-19 Trials
Canadian researchers are active amidst the COVID-19 pandemic, investigating drugs and vaccines for the treatment and prevention of this...

FDA Approves Artificial Intelligence for Detecting Suspicious Mammography Lesions
This week Zebra Medical announced the FDA approval for their HealthMammo artificial intelligence system. This system scans mammograms and...

World’s Largest Cancer Conference Goes Virtual Next Week
The American Society of Clinical Oncology (ASCO) Annual Meeting is the world’s largest cancer research conference. It was originally...

The Impact of COVID-19 on Clinical Trial Research
Amid the COVID-19 pandemic, clinical trials are running into challenges with how they conduct their research. These challenges may arise...

When a Virus Attacks – How Pharma is Responding to the Novel Coronavirus
You can’t turn on the news without hearing an update on the growing concern surrounding the spread of the latest coronavirus (known as...

Opioid Vending Machines: Perfect Solution or Perfect Storm?
Since Vancouver declared a state of emergency in 2016, the city has been infamously known as the opioid-overdose capital of Canada. With...

Potential first-in-class drug aims to provide acute relief for agitation
Agitation constitutes up to 10% of psychiatric intervention. Summarized by 5 behavioural elements (poor impulse control, tension,...

Concussion? A blood test can give the answer
Traumatic brain injuries (TBIs), of which concussions are most common, are considered an invisible epidemic. An analysis of self-reported...

The Debate on National Pharmacare
Last week, more than 1,200 health care and public policy experts signed an open letter to the federal party leaders, asking them to...